Kronos Bio Inc (NASDAQ:KRON) currently has a daily average trading volume of 513.90K but it saw 1287854 shares traded in last market. With a market cap of 40.94M USD, the company’s current market price of $0.67 came rising about 0.15 while comparing to the previous closing price of $0.67. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.60 and as low as $0.65.
Piper Sandler downgraded its recommendation for the stock as a “Neutral” from “Overweight” on November 14, 2024 while assigning a price target range of $6-$1. Berenberg issued its recommendations for the stock as it initiated the price target for the stock is $12.
Over the week, KRON’s stock price is moving 0.07% up while it is -25.31% when we observe its performance for the past one month. Year-to-date it is -29.32% down and over the past year, the stock is showing a downside performance of -11.14%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Kronos Bio Inc’s total number of outstanding shares is 60.97M with 24.31% of that held by the insiders while 31.44% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -64.32% and return on equity (ROE) at -59.49%. Stock’s beta reads 1.65. Stock has a price to book (P/B) ratio of 0.51 while price to sale or P/S ratio amounts to 4.45. Its return on asset (ROA) is -44.30% on average.
